2018
DOI: 10.5694/mja18.00635
|View full text |Cite
|
Sign up to set email alerts
|

A new evidence‐based guideline for assessment and management of polycystic ovary syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
30
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 30 publications
(47 citation statements)
references
References 14 publications
1
30
0
Order By: Relevance
“…A summary of the recommendations is published elsewhere 20 . ‐ 22 The MJA has also published an editorial accompanying this supplement 23 …”
Section: Guideline Development Process and Methodsmentioning
confidence: 99%
“…A summary of the recommendations is published elsewhere 20 . ‐ 22 The MJA has also published an editorial accompanying this supplement 23 …”
Section: Guideline Development Process and Methodsmentioning
confidence: 99%
“…oligo-amenorrhoea) and associated hormonal disturbances (eg. hyperandrogenism) (6). Based on several RCTs, the efficacy of such treatment is even comparable to placebo in improving the hormonal disturbances, including total testosterone and free androgen index (6).…”
Section: Current Treatment Guidelinesmentioning
confidence: 99%
“…Polycystic ovary syndrome (PCOS) is a complex metabolic disorder and the most common endocrine disorder in reproductive-age women that affects between 5-20% of this age group (28). The clinical expression of PCOS varies but commonly includes oligo-ovulation or anovulation, hyperandrogenism (either clinical or biochemical), and the presence of polycystic ovaries (29).…”
Section: Polycystic Ovary Syndromementioning
confidence: 99%